All News

2018

October

Media Release / Oct 10, 2018

Novartis announces new data from the first direct head-to-head trial to demonstrate superior efficacy of Gilenya® over Copaxone® in patients with relapsing remitting multiple sclerosis

Read More
Marjorie Eiref (left) and Beata Henry getting the job done
Story / Oct 10, 2018

Women in Science: Marjorie Eiref

Marjorie Eiref, Head of Operations for Neuroscience Research at Novartis, describes how her family medical history has impacted her career.

Read More
Media Release / Oct 10, 2018

Breadth of data at ECTRIMS underpins Novartis' relentless commitment to decoding the science of multiple sclerosis (MS) and decreasing the patient burden

Read More
Media Release / Oct 09, 2018

Novartis analysis shows crizanlizumab (SEG101) increased the number of patients free of sickle cell pain crises vs placebo during SUSTAIN study

Read More
Story / Oct 08, 2018

Digital health ecosystem gets a boost with the Novartis Biome

Read More
Media Release / Oct 08, 2018

Novartis announces FDA and EMA filing acceptance of siponimod, the first and only drug shown to meaningfully delay disability progression in typical SPMS patients

Read More
Media Release / Oct 04, 2018

Sandoz Healthcare Access Challenge (HACk) returns, seeking digital solutions to local healthcare access challenges

Read More
Media Release / Oct 03, 2018

Novartis licenses three novel anti-infective programs to Boston Pharmaceuticals

Read More
Surface of an engineered T cell
Story / Oct 01, 2018

Researchers boost understanding of T-cell therapy in blood cancer

Novartis investigators find genetic explanations for why some young patients relapse.

Read More

September

Media Release / Sep 24, 2018

Novartis announces five grant recipients of eXcellence in Ophthalmology Vision Award (XOVA) for nonprofit sustainable eye health initiatives

Read More

Pages

Related Links

Annual Report 2017

Review the strategy and annual performance of Novartis and read letters from our Chairman and CEO.

Learn More